Cargando…
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma
Reactivation of telomerase is a critical step in the development of hepatocellular carcinoma (HCC). Here we identified the frequency of mutations in telomerase reverse transcriptase (TERT) promoter was 34% in non-clear cell HCC (NCCHCC, n = 259) and 26.3% in clear cell HCC (CCHCC, n = 57). The mutat...
Autores principales: | Huang, Wan, Zhou, Weiping, Li, Can, Yang, Yuan, Shang, Yu-Kui, Chen, Changsheng, Zhang, Jing, Yao, Rui, Wang, Pei, Wen, Wen, Liu, Han-Qiang, Wang, Ling, Li, Xia, Bian, Huijie, Chen, Zhi-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432257/ https://www.ncbi.nlm.nih.gov/pubmed/28460432 http://dx.doi.org/10.18632/oncotarget.15458 |
Ejemplares similares
-
A case of primary clear cell hepatocellular carcinoma comprised mostly of clear cells
por: Kokubo, Reiji, et al.
Publicado: (2019) -
Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022) -
Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021) -
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
por: Yuan, Huiyang, et al.
Publicado: (2023) -
IGLL5 is correlated with tumor‐infiltrating immune cells in clear cell renal cell carcinoma
por: Xia, Zhi‐Nan, et al.
Publicado: (2021)